103 related articles for article (PubMed ID: 8885674)
1. Safety evaluation of SPf66 malaria vaccine in Brazil.
Urdaneta M; Prata A; Struchiner CJ; Tosta CE; Tauil P; Boulos M
Rev Soc Bras Med Trop; 1996; 29(5):497-501. PubMed ID: 8885674
[TBL] [Abstract][Full Text] [Related]
2. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group.
Nosten F; Luxemburger C; Kyle DE; Ballou WR; Wittes J; Wah E; Chongsuphajaisiddhi T; Gordon DM; White NJ; Sadoff JC; Heppner DG
Lancet; 1996 Sep; 348(9029):701-7. PubMed ID: 8806288
[TBL] [Abstract][Full Text] [Related]
3. Efficacy trial of malaria vaccine SPf66 in Gambian infants.
D'Alessandro U; Leach A; Drakeley CJ; Bennett S; Olaleye BO; Fegan GW; Jawara M; Langerock P; George MO; Targett GA
Lancet; 1995 Aug; 346(8973):462-7. PubMed ID: 7637479
[TBL] [Abstract][Full Text] [Related]
4. SPf66 malaria vaccine is safe and immunogenic in malaria naive adults in Thailand.
Migasena S; Heppner DG; Kyle DE; Chongsuphajaisiddhi T; Gordon DM; Suntharasamai P; Permpanich B; Brockman A; Pitiuttutham P; Wongsrichanalai C; Srisuriya P; Phonrat B; Pavanand K; Viravan C; Ballou WR
Acta Trop; 1997 Sep; 67(3):215-27. PubMed ID: 9241386
[TBL] [Abstract][Full Text] [Related]
5. SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission.
Teuscher T; Schellenberg JR; Bastos de Azevedo I; Hurt N; Smith T; Hayes R; Masanja H; Silva Y; Lopez MC; Kitua A
Vaccine; 1994 Mar; 12(4):328-36. PubMed ID: 8178555
[TBL] [Abstract][Full Text] [Related]
6. Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador.
Sempértegui F; Estrella B; Moscoso J; Piedrahita L; Hernández D; Gaybor J; Naranjo P; Mancero O; Arias S; Bernal R
Vaccine; 1994 Mar; 12(4):337-42. PubMed ID: 8178556
[TBL] [Abstract][Full Text] [Related]
7. Humoral immune response to the anti-malaria vaccine SPf66 in the Colombian Atrato River region.
Lopera TM; Restrepo M; Blair S; García HI
Mem Inst Oswaldo Cruz; 1998; 93(4):495-500. PubMed ID: 9711340
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of the synthetic malaria vaccine SPf66 in a large field trial.
Amador R; Moreno A; Murillo LA; Sierra O; Saavedra D; Rojas M; Mora AL; Rocha CL; Alvarado F; Falla JC
J Infect Dis; 1992 Jul; 166(1):139-44. PubMed ID: 1607685
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of SPf66 malaria vaccine efficacy in Brazil.
Urdaneta M; Prata A; Struchiner CJ; Tosta CE; Tauil P; Boulos M
Am J Trop Med Hyg; 1998 Mar; 58(3):378-85. PubMed ID: 9546423
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.
Valero MV; Amador LR; Galindo C; Figueroa J; Bello MS; Murillo LA; Mora AL; Patarroyo G; Rocha CL; Rojas M
Lancet; 1993 Mar; 341(8847):705-10. PubMed ID: 8095622
[TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21.
Kashala O; Amador R; Valero MV; Moreno A; Barbosa A; Nickel B; Daubenberger CA; Guzman F; Pluschke G; Patarroyo ME
Vaccine; 2002 May; 20(17-18):2263-77. PubMed ID: 12009282
[TBL] [Abstract][Full Text] [Related]
12. Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara.
Thera MA; Coulibaly D; Kone AK; Guindo AB; Traore K; Sall AH; Diarra I; Daou M; Traore IM; Tolo Y; Sissoko M; Niangaly A; Arama C; Baby M; Kouriba B; Sissoko MS; Sagara I; Toure OB; Dolo A; Diallo DA; Remarque E; Chilengi R; Noor R; Sesay S; Thomas A; Kocken CH; Faber BW; Imoukhuede EB; Leroy O; Doumbo OK
Malar J; 2016 Aug; 15(1):442. PubMed ID: 27577237
[TBL] [Abstract][Full Text] [Related]
13. A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela.
Noya O; Gabaldón Berti Y; Alarcón de Noya B; Borges R; Zerpa N; Urbáez JD; Madonna A; Garrido E; Jimenéz MA; Borges RE
J Infect Dis; 1994 Aug; 170(2):396-402. PubMed ID: 8035026
[TBL] [Abstract][Full Text] [Related]
14. A pilot safety and immunogenicity study of the malaria vaccine SPf66 in Gambian infants.
Leach A; Drakeley CJ; D'Alessandro U; Fegan GW; Bennett S; Ballou WR; Targett GA; Greenwood BM
Parasite Immunol; 1995 Aug; 17(8):441-4. PubMed ID: 7501425
[TBL] [Abstract][Full Text] [Related]
15. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.
Alonso PL; Smith T; Schellenberg JR; Masanja H; Mwankusye S; Urassa H; Bastos de Azevedo I; Chongela J; Kobero S; Menendez C
Lancet; 1994 Oct; 344(8931):1175-81. PubMed ID: 7934537
[TBL] [Abstract][Full Text] [Related]
16. A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and design.
Alonso PL; Tanner M; Smith T; Hayes RJ; Schellenberg JA; Lopez MC; Bastos de Azevedo I; Menendez C; Lyimo E; Weiss N
Vaccine; 1994 Feb; 12(2):181-6. PubMed ID: 8147101
[TBL] [Abstract][Full Text] [Related]
17. Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66.
Haywood M; Conway DJ; Weiss H; Metzger W; D'Alessandro U; Snounou G; Targett G; Greenwood B
Trans R Soc Trop Med Hyg; 1999 Feb; 93 Suppl 1():65-8. PubMed ID: 10450429
[TBL] [Abstract][Full Text] [Related]
18. SPf66 vaccine trial in Brazil: conceptual framework study design and analytical approach.
Urdaneta M; Prata A; Struchiner CJ; Tosta CE; Tauil P; Boulos M
Rev Soc Bras Med Trop; 1996; 29(3):259-69. PubMed ID: 8701046
[TBL] [Abstract][Full Text] [Related]
19. Safety in infants of SPf66, a synthetic malaria vaccine, delivered alongside the EPI.
Schellenberg DM; Acosta CJ; Galindo CM; Kahigwa E; Urassa H; Masanja H; Aponte JJ; Schellenberg JR; Fraser-Hurt N; Lwilla F; Menendez C; Mshinda H; Tanner M; Alonso PL
Trop Med Int Health; 1999 May; 4(5):377-82. PubMed ID: 10402974
[TBL] [Abstract][Full Text] [Related]
20. Vaccines for preventing malaria.
Graves P; Gelband H
Cochrane Database Syst Rev; 2000; (2):CD000129. PubMed ID: 10796492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
